Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: wlcnyc who wrote (110861)	3/12/2004 9:39:23 AM
From: Connor26	Respond to of 208838

if this opening doesn't hold up and get even better we're in big trouble!

To: wlcnyc who wrote (110861)	3/12/2004 9:58:16 AM
From: hotlinktuna	Respond to of 208838

Thanks Bill, you too! I added NSTK 13.79 +.44 due to their work on reducing hunger through the use of a nasal spray...CEO was on CNBC a day or two ago...here's recent headlines: Nastech Gets 2nd Patent For Breast Disease Detection Tech Thu 1:00pm - Dow Jones Business News • Nastech Receives Second U.S. Patent for FDA-Approved Mammary Aspirate Specimen Cytology Test for Breast Cancer Thu 9:00am - PR Newswire • Nastech Pharmaceuticals Fourth Quarter 2004 Financial Results Call scheduled for 11:00 am ET today Wed, Mar 10 - First Call Events • Nastech Announces Fourth Quarter and 2003 Financial Results Wed, Mar 10 - PR Newswire • Nastech Reports Positive PYY Obesity and Apomorphine Sexual Dysfunction Clinical Trial Data Wed, Mar 10 - PR Newswire • Q4 2003 Nastech Pharmaceuticals Earnings Release - Before Market Open Wed, Mar 10 - CCBN • Nastech to Release Fourth Quarter and Year End Financial Results and Host Webcast on Wednesday, March 10, 2004 Wed, Mar 3 - PR Newswire • Nastech Initiates Phase Ic Dose-Sequencing Study Using PYY3-36 Obesity Drug Nasal Spray Tue, Feb 24 - PR Newswire • Nastech to Present its PYY Obesity Program at the 6th Annual BIO CEO & Investor Conference Wed, Feb 18 - PR Newswire • Nastech Announces FDA Acceptance of ANDA Filing for Calcitonin-Salmon Nasal Spray Tue, Feb 17 - PR Newswire More Headlines for NSTK... The 52wk high is around 14.40 I believe, so it's getting fairly close to the high....looking at this for a bit longer term....tuna